Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Post Marketing Surveillance Study For Observing Safety And Efficacy Of Lyrica

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01220180
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:51.016876+00:00
Published At
2011-12-08T00:00:00+00:00
Record Updated At
2021-01-25
Results Posted At
2011-12-08
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Epilepsy", "Neuropathic Pain", "Fibromyalgia", "Post-market Surveillance"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-01-25"
protocolSection.identificationModule.nctId
"NCT01220180"
protocolSection.identificationModule.officialTitle
"Post Marketing Surveillance Study For Observing Safety And Efficacy Of Lyrica"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2011-12-08"

Study condition terms

  • Epilepsy (protocolSection.conditionsModule.conditions)
  • Neuropathic Pain (protocolSection.conditionsModule.conditions)
  • Fibromyalgia (protocolSection.conditionsModule.conditions)
  • Post-market Surveillance (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.